Drug Master Files for: rizatriptan benzoate
✉ Email this page to a colleague
rizatriptan benzoate Drug Master Files
| DMF No. | Status | Type | Submission Date | Holder | Subject |
|---|---|---|---|---|---|
| 17633 | I | II | 8/30/2004 | CIPLA LTD | RIZATRIPTAN BENZOATE |
| 18021 | A | II | 1/26/2005 | CIPLA LTD | RIZATRIPTAN BENZOATE USP |
| 19098 | A | II | 1/10/2006 | MYLAN LABORATORIES LTD | RIZATRIPTAN BENZOATE USP |
| 19179 | A | II | 2/14/2006 | DR REDDYS LABORATORIES LTD | RIZATRIPTAN BENZOATE USP |
| 20781 | A | II | 8/21/2007 | NATCO PHARMA LTD | RIZATRIPTAN BENZOATE |
| 22676 | A | II | 3/31/2009 | GLENMARK PHARMACEUTICALS LTD | RIZATRIPTAN BENZOATE USP |
| >DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information
